Literature DB >> 16901894

A point mutation in the SH1 helix alters elasticity and thermal stability of myosin II.

Sosuke Iwai1, Daisuke Hanamoto, Shigeru Chaen.   

Abstract

Movement generated by the myosin motor is generally thought to be driven by distortion of an elastic element within the myosin molecule and subsequent release of the resulting strain. However, the location of this elastic element in myosin remains unclear. The myosin motor domain consists of four major subdomains connected by flexible joints. The SH1 helix is the joint that connects the converter subdomain to the other domains, and is thought to play an important role in arrangements of the converter relative to the motor. To investigate the involvement of the SH1 helix in elastic distortion in myosin, we have introduced a point mutation into the SH1 helix of Dictyostelium myosin II (R689H), which in human nonmuscle myosin IIA causes nonsyndromic hereditary deafness, DFNA17. The mutation resulted in a significant impairment in motile activities, whereas actin-activated ATPase activity was only slightly affected. Single molecule mechanical measurements using optical trap showed that the step size was not shortened by the mutation, suggesting that the slower motility is caused by altered kinetics. The single molecule measurements demonstrated that the mutation significantly reduced cross-bridge stiffness. Motile activities produced by mixtures of wild-type and mutant myosins also suggested that the mutation affected the elasticity of myosin. These results suggest that the SH1 helix is involved in modulation of myosin elasticity, presumably by modulating the converter flexibility. Consistent with this, the mutation was also shown to reduce thermal stability and induce thermal aggregation of the protein, which might be implicated in the disease process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16901894     DOI: 10.1074/jbc.M605365200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II.

Authors:  Hariyadarshi Pannu; Van Tran-Fadulu; Christina L Papke; Steve Scherer; Yaozhong Liu; Caroline Presley; Dongchuan Guo; Anthony L Estrera; Hazim J Safi; Allan R Brasier; G Wesley Vick; A J Marian; C S Raman; L Maximilian Buja; Dianna M Milewicz
Journal:  Hum Mol Genet       Date:  2007-07-31       Impact factor: 6.150

2.  Expression of the inclusion body myopathy 3 mutation in Drosophila depresses myosin function and stability and recapitulates muscle inclusions and weakness.

Authors:  Yang Wang; Girish C Melkani; Jennifer A Suggs; Anju Melkani; William A Kronert; Anthony Cammarato; Sanford I Bernstein
Journal:  Mol Biol Cell       Date:  2012-04-11       Impact factor: 4.138

3.  Mutations in the SH1 helix alter the thermal properties of myosin II.

Authors:  Kotomi Shibata; Tsubasa Koyama; Shohei Inde; Sosuke Iwai; Shigeru Chaen
Journal:  Biophys Physicobiol       Date:  2017-05-31

4.  Establishment of mouse model of MYH9 disorders: heterozygous R702C mutation provokes macrothrombocytopenia with leukocyte inclusion bodies, renal glomerulosclerosis and hearing disability.

Authors:  Nobuaki Suzuki; Shinji Kunishima; Makoto Ikejiri; Shoichi Maruyama; Michihiko Sone; Akira Takagi; Masahito Ikawa; Masaru Okabe; Tetsuhito Kojima; Hidehiko Saito; Tomoki Naoe; Tadashi Matsushita
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.